临床与实验病理学杂志
臨床與實驗病理學雜誌
림상여실험병이학잡지
Chinese Journal of Clinical and Experimental Pathology
2015年
9期
966-970
,共5页
尹燕雪%李传伟%于爱莲%王学春
尹燕雪%李傳偉%于愛蓮%王學春
윤연설%리전위%우애련%왕학춘
乳腺肿瘤%干细胞%悬浮微球体细胞%CD44+/CD24-/low表型干细胞
乳腺腫瘤%榦細胞%懸浮微毬體細胞%CD44+/CD24-/low錶型榦細胞
유선종류%간세포%현부미구체세포%CD44+/CD24-/low표형간세포
breast neoplasm%stem cell%suspended microsphere cells%CD44 + /CD24 -/low phenotype cells
目的:探讨无血清培养技术从人乳腺癌MCF-7细胞株中有效富集乳腺癌干细胞的影响。方法采用无血清和有血清两种培养技术分别培养人乳腺癌MCF-7细胞株,观察并收集两种细胞,对CD24、CD44标志物进行免疫荧光染色;使用倒置荧光显微镜检测该标志物的表达差异;应用流式细胞仪检测不同亚群细胞的比例,并检测两种细胞周期的差异。结果无血清培养的细胞以大小不等的微球体形式在培养液中悬浮生长,有血清培养的细胞以类似多边形的形式在培养液中单层贴壁生长。 CD44在悬浮微球体细胞和贴壁细胞中的表达无明显差异,CD24在悬浮微球体细胞中的表达明显减少;悬浮微球体细胞和贴壁细胞中CD44+/CD24-/low表型细胞的比例分别为(86.93±0.53)%和(19.98±0.62)%(P<0.05),CD44+/CD24+表型细胞的比例分别为(12.68±0.59)%和(79.90±0.57)%(P<0.05)。分裂期(S)细胞在悬浮微球体细胞和贴壁细胞中的比例分别为(18.85±2.26)%和(43.91±1.81)%(P<0.05);静止期(G1)细胞的比例分别为(64.92±2.07)%和(39.82±1.77)%(P<0.05)。结论无血清培养技术可以有效富集CD44+/CD24-/low表型乳腺癌干细胞。
目的:探討無血清培養技術從人乳腺癌MCF-7細胞株中有效富集乳腺癌榦細胞的影響。方法採用無血清和有血清兩種培養技術分彆培養人乳腺癌MCF-7細胞株,觀察併收集兩種細胞,對CD24、CD44標誌物進行免疫熒光染色;使用倒置熒光顯微鏡檢測該標誌物的錶達差異;應用流式細胞儀檢測不同亞群細胞的比例,併檢測兩種細胞週期的差異。結果無血清培養的細胞以大小不等的微毬體形式在培養液中懸浮生長,有血清培養的細胞以類似多邊形的形式在培養液中單層貼壁生長。 CD44在懸浮微毬體細胞和貼壁細胞中的錶達無明顯差異,CD24在懸浮微毬體細胞中的錶達明顯減少;懸浮微毬體細胞和貼壁細胞中CD44+/CD24-/low錶型細胞的比例分彆為(86.93±0.53)%和(19.98±0.62)%(P<0.05),CD44+/CD24+錶型細胞的比例分彆為(12.68±0.59)%和(79.90±0.57)%(P<0.05)。分裂期(S)細胞在懸浮微毬體細胞和貼壁細胞中的比例分彆為(18.85±2.26)%和(43.91±1.81)%(P<0.05);靜止期(G1)細胞的比例分彆為(64.92±2.07)%和(39.82±1.77)%(P<0.05)。結論無血清培養技術可以有效富集CD44+/CD24-/low錶型乳腺癌榦細胞。
목적:탐토무혈청배양기술종인유선암MCF-7세포주중유효부집유선암간세포적영향。방법채용무혈청화유혈청량충배양기술분별배양인유선암MCF-7세포주,관찰병수집량충세포,대CD24、CD44표지물진행면역형광염색;사용도치형광현미경검측해표지물적표체차이;응용류식세포의검측불동아군세포적비례,병검측량충세포주기적차이。결과무혈청배양적세포이대소불등적미구체형식재배양액중현부생장,유혈청배양적세포이유사다변형적형식재배양액중단층첩벽생장。 CD44재현부미구체세포화첩벽세포중적표체무명현차이,CD24재현부미구체세포중적표체명현감소;현부미구체세포화첩벽세포중CD44+/CD24-/low표형세포적비례분별위(86.93±0.53)%화(19.98±0.62)%(P<0.05),CD44+/CD24+표형세포적비례분별위(12.68±0.59)%화(79.90±0.57)%(P<0.05)。분렬기(S)세포재현부미구체세포화첩벽세포중적비례분별위(18.85±2.26)%화(43.91±1.81)%(P<0.05);정지기(G1)세포적비례분별위(64.92±2.07)%화(39.82±1.77)%(P<0.05)。결론무혈청배양기술가이유효부집CD44+/CD24-/low표형유선암간세포。
Purpose To identify whether serum-free culture can enrich breast cancer stem cells from MCF-7 human breast cancer cell line. Methods MCF-7 human breast cancer cell line by serum-free culture and serum culture technology were cultured, its cell mor-phology and growth pattern were observed by the inverted microscope. The expression of stem cell surface molecular makers CD24, CD44 was observed by the inverted fluorescence microscope and the flow cytometry, the proportion of different subpopulation cells was detected by the flow cytometry. At the same time, difference of the cell cycle was detected by the flow cytometry. Results The cell line cultured by serum-free culture grew in the form of suspended microspheres of different sizes in the medium, but the cell line cul-tured by serum culture grew in the form of monolayer adherent growth. There was no obvious difference in the expression of stem cell surface molecular makers CD44 between the suspended microsphere cells and the adherent cells, but the expression of CD24 in the sus-pended microsphere cells decreased compared to the adherent cells. The proportion of CD44 + /CD24 -/low phenotype cells in the suspen-ded microsphere cells and the adherent cells was (86. 93 ± 0. 53)% and (19. 98 ± 0. 62)%, respectively (P<0. 05), the proportion of CD44 + /CD24 + phenotype cells was (12. 68 ± 0. 59)% and (79. 90 ± 0. 57)%, respectively (P<0. 05). The proportion of mitotic cells in the suspended microsphere cells and the adherent cells was ( 18. 85 ± 2. 26 )% and ( 43. 91 ± 1. 81 )%, respectively ( P<0. 05), the proportion of quiescent cells was (64. 92 ± 2. 07)% and (39. 82 ± 1. 77)%, respectively (P<0. 05). Conclusion CD44 + /CD24 -/low breast cancer stem cells can be effectively enriched by the serum-free culture technology.